drugset / Trial / NCT01691209
Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis
Withdrawn
Bayer
RandomizedParallel-groupSingle-blindTreatment
Summary
The study shall explore whether treatment of atopic dermatitis is equally effective with Phoenix medical device as compared to standard therapy (Hydrocortisone cream).
Timeline
- Start
- 2013-10
- Primary completion
- 2014-04
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocortisone | Other / unclassified | 1 % | Topical |